Literature DB >> 11672769

Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

S H Koo1, C H Ihm, K C Kwon, J W Park, J M Kim, G Kong.   

Abstract

In the following study, we used comparative genomic hybridization (CGH) to screen and compare for genetic alterations of hepatocellular carcinoma (HCC) and intrahepatic choalgiocarcinoma (ICC). The studies showed distinctive features of genetic alterations between the two tumors. Characteristic abnormal changes for HCC were 1q gain and loss of 4q, 10q and 13q regions. In contrast, gains of 5p, 7p, 13q and 20q were more predominant in ICC. Losses of 16q, 17p, and 18q, and gain of 8q region showed a similar high frequency of incidence in both tumors. The most striking and different findings were 1q amplification in HCC and 20q gain in ICC. Our data indicate that ICC shows the pattern of genetic alterations similar to pancreatic and colorectal cancers. This suggests that the genetic alterations in tumorigenesis show a similar pattern depending on the origin of cells, not the organ.

Entities:  

Mesh:

Year:  2001        PMID: 11672769     DOI: 10.1016/s0165-4608(01)00460-5

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  13 in total

1.  Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.

Authors:  Siobhan C McKay; Kristian Unger; Stephanos Pericleous; Gordon Stamp; Gerry Thomas; Robert R Hutchins; Duncan R C Spalding
Journal:  HPB (Oxford)       Date:  2011-03-10       Impact factor: 3.647

2.  Genome-wide single nucleotide polymorphism array analysis reveals recurrent genomic alterations associated with histopathologic features in intrahepatic cholangiocarcinoma.

Authors:  Wan-Ting Huang; Shao-Wen Weng; Yu-Ching Wei; Huey-Ling You; Jui-Tzu Wang; Hock-Liew Eng
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 3.  Genetic profiling of intrahepatic cholangiocarcinoma.

Authors:  Jesper B Andersen; Snorri S Thorgeirsson
Journal:  Curr Opin Gastroenterol       Date:  2012-05       Impact factor: 3.287

Review 4.  Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies.

Authors:  D Sia; V Tovar; A Moeini; J M Llovet
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

Review 5.  Pathogenesis, diagnosis, and management of cholangiocarcinoma.

Authors:  Sumera Rizvi; Gregory J Gores
Journal:  Gastroenterology       Date:  2013-10-15       Impact factor: 22.682

6.  Clinical and biological significance of precursor lesions of intrahepatic cholangiocarcinoma.

Authors:  Mark Ettel; Ogechukwu Eze; Ruliang Xu
Journal:  World J Hepatol       Date:  2015-11-08

Review 7.  An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma.

Authors:  Pattaya Seeree; Phorutai Pearngam; Supeecha Kumkate; Tavan Janvilisri
Journal:  Int J Genomics       Date:  2015-09-02       Impact factor: 2.326

8.  miRNA-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting PDCD4.

Authors:  Miao Yang; Ran Liu; Xiajun Li; Juan Liao; Yuepu Pu; Enchun Pan; Lihong Yin; Yi Wang
Journal:  Mol Cells       Date:  2014-12-10       Impact factor: 5.034

9.  Genetic alterations in intrahepatic cholangiocarcinoma as revealed by degenerate oligonucleotide primed PCR-comparative genomic hybridization.

Authors:  Ji-Young Lee; Young-Nyun Park; Kyung-Ok Uhm; Soo-Yeun Park; Sun-Hwa Park
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

10.  Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data.

Authors:  Joseph J Crawley; Kyle A Furge
Journal:  Genome Biol       Date:  2002-11-25       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.